Merck   4Q Revenues: $10.2 billion (-3%) 4Q Earnings: $976 million (earnings were $7.3 billion 4Q14) FY Revenues: $39.5 billion (-6%) FY Earnings: $4.4 billion (earnings were $11.9 billion FY14) Comments: Revenues include a 7% negative impact from foreign exchange and 3% favorable impact from acquisitions and divestitures, primarily the acquisition of Cubist Pharmaceuticals. Januvia sales were down 12% to $1.4 billion likely due to a recent FDA safety alert about risk of joint pain...